Venetoclax Shown Great Results with Bortezomib It targets 11;14, oral, well-tolerated
Paul G. Richardson, MD, explains Venetoclax Shown Great Results with Bortezomib It targets 11;14, oral, well-tolerated at Imedex Great Debates 2018.
Author: hematologydebates
Added: 05/08/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts